Paclitaxel-releasing balloon catheter - Blue Medical

Drug Profile

Paclitaxel-releasing balloon catheter - Blue Medical

Alternative Names: Protege DEB Catheter; Protege DEB NC; Protege non compliant DEB Catheter; Protégé; Protégé NC

Latest Information Update: 12 Nov 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Blue Medical
  • Class Antineoplastics; Diterpenes; Paclitaxels; Small molecules; Taxanes
  • Mechanism of Action Mitosis inhibitors; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Coronary artery disease

Most Recent Events

  • 30 May 2013 Biomarkers information updated
  • 30 Oct 2012 Registered for Coronary artery disease (non-compliant paclitaxel-eluting balloon incorporating Force® catheter) in European Union (Intracoronary)
  • 20 Mar 2012 Launched for Coronary artery disease in European Union (Intracoronary) - first global launch
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top